Your browser doesn't support javascript.
loading
[IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study]. / IDA-FLAG (Idarubicin, Fludarabin, hochdosiertes Cytarabin und G-CSF)-Ein effektives Therapieschema in der Behandlung von AML-Rezidiven bei Kindern und Jugendlichen. Erste Ergebnisse einer Pilotstudie.
Fleischhack, G; Graf, N; Hasan, C; Ackermann, M; Breu, H; Zernikow, B; Bode, U.
Affiliation
  • Fleischhack G; Universitätskinderklinik Bonn.
Klin Padiatr ; 208(4): 229-35, 1996.
Article in De | MEDLINE | ID: mdl-8926688
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Remission Induction / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Language: De Journal: Klin Padiatr Year: 1996 Document type: Article Country of publication: Germany
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Remission Induction / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Language: De Journal: Klin Padiatr Year: 1996 Document type: Article Country of publication: Germany